Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Window of Implantation
Inhibitor Therapeutics
IVF
1 trial -
Within-subjects (MDMA)
BRIGHT MINDS BIOSCIENCES INC.
Drug Addiction
1 trial -
Wobenzym PS
Atrium Therapeutics
Sub-clinical Inflammation
1 trial -
WonderLab Collagen Tripeptide Drink
Chongqing Precision Biotech Co., Ltd
Skin Laxity
1 trial -
Wonderlab Kids instant probiotics
Chongqing Precision Biotech Co., Ltd
Immunity
1 trial -
Wonderlab Nicotinamide Drink
Chongqing Precision Biotech Co., Ltd
Skin Darken
1 trial -
Xuebi formula
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetic Peripheral Neuropathy
1 trial -
Yinxingmihuan oral solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Stable Angina
1 trial -
YishenShujin Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Fibromyalgia Syndrome
1 trial -
ZS801
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hemophilia B
1 trial -
ZhenQi BuXue KouFuYe
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Menstrual Disorders
1 trial -
active nicotine gum
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
active tDCS and cognitive training intervention
United Therapeutics Europe Ltd
Brain Concussion
2 trials -
adefovir dipivoxil
Hospital Authority, Hong Kong
Hepatitis B
1 trial -
alteplase or tenecteplase
United Therapeutics Europe Ltd
CVA (Cerebrovascular Accident)
1 trial -
amorphous calcium carbonate/ Placebo
Universal Integrated
Calcium
1 trial -
anti-CD19/BCMA-UCAR-T cells
The First People's Hospital of Lianyungang
Rheumatoid Arthritis
1 trial -
anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Effect Increased
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Immunologic Deficiency Syndromes
1 trial -
anti-thymocyte globulin
United Therapeutics Europe Ltd
Leukemia
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Chediak-Higashi Syndrome
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Graft Versus Host Disease
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Neutropenia
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Purpura, Schoenlein-Henoch
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources